GLYPICAN 2 AS A CANCER MARKER AND THERAPEUTIC TARGET
- 专利权人:
- THE CHILDRENS HOSPITAL OF PHILADELPHIA
- 发明人:
- MARIS, JOHN M.,BOSSE, KRISTOPHER R.,DIMITROV, DIMITER,ZHU, ZHONGYU
- 申请号：
- CA3004438
- 公开号：
- CA3004438A1
- 申请日:
- 2016.11.08
- 申请国别(地区):
- CA
- 年份:
- 2017
- 代理人:
- 摘要：
- The present disclosure is directed to antibodies binding to Glypican 2 and methods of using such antibodies to treat cancers that express or overexpress the Glypican 2 antigen.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Glypican 2 as a cancer marker and therapeutic target
- Hyper enhanced baculovirus expression vector with increased production of foreign proteins by early expression
- IMPROVED PROCESS FOR EXPRESSION, PURIFICATION AND ENHANCED RECOVERY OF MYCOBACTERIAL RECOMBINANT PROTEINS
- PROCEDE POUR REGULER A LA HAUSSE L'EXPRESSION D'UN ANTIGENE
- Immunocompetent cell and expression vector expressing regulatory factors of immune function
